Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
Open accessThe DOI matches its Crossref record; 244 of the 246 references it cites were found in a registry or an index.
Abstract
Background.: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain. Methods.: A task force supported by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America searched, selected, and synthesized relevant evidence. The evidence was then used as the basis for recommendations about the diagnosis of tuberculosis disease and LTBI in adults and children. The recommendations were formulated, written, and graded using the Grading, Recommendations, Assessment, Development and Evaluation (GRADE) approach. Results.: Twenty-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tuberculosis, and extrapulmonary tuberculosis are provided. Six of the recommendations are strong, whereas the remaining 17 are conditional. Conclusions.: These guidelines are not intended to impose a standard of care. They provide the basis for rational decisions in the diagnosis of tuberculosis in the context of the existing evidence. No guidelines can take into account all of the often compelling unique individual clinical circumstances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, culture may lead to misclassification of some cases of extrapulmonary tuberculosis as ‘not tuberculosis', owing to the paucibacillary nature of the disease.”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“This means that culture may have low sensitivity for extrapulmonary tuberculosis overall and further that culture sensitivity may differ for different forms of extrapulmonary tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“A recent evidence synthesis reported sensitivities of 72% to 88% in lymph node tissue, 28% to 81% in pleural fluid, 90% in pleural tissue, and 31% to 56% in CSF. Specificity ranged from 90% to 100% (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“For the 'Summary of findings' tables for CSF and pleural fluid, we provide evidence using culture as the reference standard, which is considered the best reference standard for tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 3×
“These assays are promising, but are not yet commercially available [146, 159, 160].”
BackgroundMethodGrading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732 · cited 1×
“The emergence of drug-resistant tuberculosis has become apparent over the past 2 decades, and in particular, multidrug-resistant tuberculosis (MDR-TB; resistant to isoniazid and rifampin) and extensively drug-resistant tuberculosis (XDR-TB; resistant to isoniazid and rifampin, plus any fluoroquinolone and at least 1 o…”
BackgroundSelwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574 · cited 1×
“For example, individuals who have a prior latent infection with Mtb (not treated) and then acquire HIV infection will develop TB disease at an approximate rate of 5%–10% per year (in the absence of effective HIV treatment) [18, 19].”
Background(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Self-citationMolecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Research works printed but not linked: 8
- World Health Organization, 2015, Global tuberculosis report 2015
- T-SPOT.TB: an aid in the diagosis of tuberculosis infection; package insert for in vitro diagnositic use
- Perez, 2005, Impact of screening for latent TB before initiating anti-TNF therapy in North America and Europe, Ann Rheum Dis, 64, 265
- US Food and Drug Administration, 2008, Medical devices: T-SPOT-TB—P070006
- Forbes, 2008, Laboratory detection and identification of mycobacteria; approved guideline
- Francis J. Curry National Tuberculosis Center and California Department of Public Health, 2008, Drug-resistant tuberculosis: a survival guide for clinicians
- World Health Organization, 2008, Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB)
- Ena, 1990, The usefulness and limitations of adenosine deaminase in the diagnosis of tubercular pleurisy. A meta-analytical study [in Spanish], Med Clin (Barc), 95, 333
Cited by
Items 901–992 of 992
Reactivation of Pulmonary Tuberculosis After 64 Years: Case Report
Carrillo-Vázquez, C., Dzul-Caballero, J. E., & May, V. G. S. (2024) · British journal of healthcare and medical research · doi:10.14738/bjhmr.115.17698
Decision Intelligence for Healthcare Decarbonization
Nadarajah, S., & Dziemian, S. (2025) · Foundations and Trends® in Technology Information and Operations Management · doi:10.1561/0200000116-4
Commentary on Acute Sodium Fluctuation in Altered Consciousness: A Puzzle or a Key to Diagnosis?
Geaghan, S. M. (2025) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaf016
Distribuição espacial da tuberculose em menores de 15 anos, Pernambuco, 2013-2022
de Oliveira, R. D. N., Silva, A. P. D. S. C., do Bonfim, C. V., Teixeira, C. S. S., & Miranda, G. M. D. (2025) · Confins · doi:10.4000/13lv3
Appendix 9.1: Hepatitis B Virus (HBV) Testing
Peter B. Lockhart DDS, F. R., DDS, L. L. P., Michael Glick DMD, F. R., & Perry H. Dubin MD, M. (2025) · doi:10.1002/9781119984382.app9
Bacterial Laboratory Diagnosis
Dunn, J. J., & Brown, C. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00268-5
New approaches in the diagnosis of tuberculous infection
Sclifos, O., Vilc, V., Iavorschi, C., & Plămadeala, O. (2024) · Bulletin of the Academy of Sciences of Moldova Medical Sciences · doi:10.52692/1857-0011.2024.2-79.48
Health economic evaluations of diagnostic tests for tuberculosis: a narrative review
Arpa, C., Wahed, A. A. E., Aydin, S., Ghosh, P., Mondal, D., Nakiyingi, L., Okuni, J. B., Schneitler, S., Weidmann, M., & Siegel, M. (2025) · Health Economics Review · doi:10.1186/s13561-025-00639-2
Preventation and Management of Infectious Diseases in Children Using Biological Response Modifiers
Tuncay, S. A., & Demir, S. Ö. (2025) · Kocaeli Üniversitesi Sağlık Bilimleri Dergisi · doi:10.30934/kusbed.1388668
Pescatore, R. M. (2025) · Emergency Medicine News · doi:10.1097/01.eem.0000000000000038
Chee, C. B. E., & Wang, Y. T. (2025) · Thorax · doi:10.1136/thorax-2025-223594
Case 21-2025: A 75-Year-Old Man with Cough, Dyspnea, and Hypoxemia
Anandaiah, A. M., Price, M. C., Alladina, J. W., Ankomah, P., & Klontz, E. H. (2025) · New England Journal of Medicine · doi:10.1056/nejmcpc2412532
Kseri, R. (2025) · doi:10.1093/med/9780197812631.003.0008
Medication Use in Infectious Diseases
Bilder, G. E., & Brown-O’Hara, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-84831-5_6
Swisher, S. D., Taetzsch, S. J., Laughlin, M. E., Walker, W. L., Lehman, K. A., Carroll, A., Bravo, D. M., Langer, A. J., & Pieracci, E. G. (2025) · Journal of the American Association for Laboratory Animal Science · doi:10.30802/aalas-jaalas-25-057
Mert, A., Derin, O., Zerdali, E. Y., Kaya, A., Gül, Ö., Borcak, D., Kurt, A. F., Koç, M. M., Kayaaslan, B., Batırel, A. A., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329267
Unveiling the Uncommon Ventriculitis in Tubercular Meningitis
Misra, G., Kosaraju, S. N., & Bhatti, B. (2025) · Cureus · doi:10.7759/cureus.89312
Shrestha, S. K., Bango, F., Samina, P., Korobitsyn, A., Ismail, N. A., & Zwerling, A. A. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004930
“Concurrent testing on multiple specimens has been shown to improve diagnostic yield to diagnose TB [9].”
Vonnahme, L. A., Ravindhran, P., Espey, J., Sharma, B., Moore, T., Aiona, K., Skarbinski, J., Narita, M., Shete, P. B., Adhimurthy, J., et al. (2025) · medRxiv · doi:10.1101/2025.08.25.25333908
Tuberculous septic pseudoaneurysm of the right subclavian artery: A rare case report
Halaouate, I., Boulahroud, I., Eddich, Y., Bakkali, T., Bounssir, A., & Lekehal, B. (2025) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2025.111886
“Tuberculosis can cause a granulomatous reaction that erodes through the vessel wall [5], resulting in a false aneurysm [6].”
Tuberculosis miliar en el adulto mayor: a propósito de un caso
Gustin, M. A. Z., Esteban, M. F., Ramos, W. F., & Betancor, É. (2025) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2025.101715
Risk Perceptions Regarding Tuberculosis Among Hispanic Adults — United States, 2020–2022
Caruso, E., Mangan, J., Maiuri, A., Bouwkamp, B., & DeLuca, N. (2025) · American Journal of Health Promotion · doi:10.1177/08901171251376650
Gutiérrez, J. M., Malone, L. L., Mohammadi, M., Mukisa, J., Atuhairwe, M., Mwesigwa, S. P. G., Athieno, S., Buwule, S., Ameda, F., Nalukwago, S., et al. (2025) · Pathogens · doi:10.3390/pathogens14090924
“In the United States, where BCG vaccination is not routinely given, the CDC and American Academy of Pediatrics recommends a threshold of 5 mm for children with known TB exposure if TST is performed [9,37].”
Pellón-Téllez, I. K., Vargas, O. E. F., Cornejo‐Juárez, P., Martin‐Onraët, A., Rubalcava-Lara, L. F., Alvidrez-González, R. A., Salcedo, A., Valero-Saldaña, L. M., & Acosta‐Maldonado, B. L. (2025) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2025.100565
“After 48 to 72 h, a hyper-sensitivity reaction with an induration of ≥ 5 mm was considered positive, as per ATS/IDSA/CDC guidelines [10], ECIL guidelines [7], and CDC recommendations [11].”
Management of Suspected Brain Infection in the ICU
Mishra, S. B., Samal, S., & Panda, S. (2025) · Springer eBooks · doi:10.1007/978-981-95-0179-3_4
Acute Pyogenic Ankle Monoarthritis Due to Tuberculosis: A Real-Life Clinical Conundrum
Ali, O., Abbas, R., Chau, S. F., Srivastava, P., & Chakravorty, M. (2025) · Cureus · doi:10.7759/cureus.94517
“…Prevention (CDC) and Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis of TB in adults and children, NAAT is suggested (conditionally) for specimens from extrapulmonary sites as a supplementary tool to culture, but not as a sole diagnostic method [15,16].”
InfluentialTopper, A., Griffin, C. A., Gopalan, A., & Huang, F. S. (2025) · American Journal of Infection Control · doi:10.1016/j.ajic.2025.11.006
Peritoneal Tuberculosis Mimicking Pseudomyxoma Peritonei: A Diagnostic Challenge
Chawla, S., Venkatesh, M. B., Birda, C. L., Aggarwal, D., & Rodha, M. S. (2025) · Cureus · doi:10.7759/cureus.97283
“…lakes [3] MRI findings Hydrosalpinx; peripheral rim enhancement [8] High T2 signal mucin; solid-cystic masses [3] Confirmatory test CBNAAT, AFB culture [1,10,11] Histopathology; mucin cytology [3] TABLE 2: Imaging and diagnostic features differentiating peritoneal TB and pseudomyxoma peritonei.”
Tantawarak, N., Lapphra, K., Vanprapar, N., Wittawatmongkol, O., Phongsamart, W., Rungmaitree, S., Lertamornkitti, N., Limpitikul, W., & Chokephaibulkit, K. (2025) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000005068
Lan, N., Tang, L., Liu, J., Xu, X., Liu, C., & Zhang, G. (2025) · Research Square · doi:10.21203/rs.3.rs-8155025/v1
Evidenzbasierter Einsatz von Interferon-Gamma Release Assays in der Tuberkulosediagnostik
Idris, R., Urschel, R., Lange, C. G., & Sester, M. (2025) · Zeitschrift für Pneumologie · doi:10.1007/s10405-025-00651-7
Palacios-Penedo, S., Arias-Guillén, M., Escalante, P., Castelló-Abiétar, C., Menéndez‐Valle, I., Ramírez-Parras, G., Buendía-Romero, P., García-García, J.-M., Riestra-Menéndez, S., Asensi-Álvarez, V., et al. (2025) · ERJ Open Research · doi:10.1183/23120541.01257-2025
Hwang, K. W., Choi, J. H., Lee, S. Y., Lee, S. Y., Chon, M. K., Lee, J., Kim, H., Kim, Y.-G., Choi, H. O., Kim, J. S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22620290
Seo, W. J., Koo, H.-K., Kang, J. Y., Kang, J., Park, S. H., Kang, H. K., Park, H. K., Lee, S.-S., Choi, S., Jang, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24633289
Martínez-Domínguez, J., Sierra-Martínez, O., Galindo‐Fraga, A., Trejo-Mejía, J. A., Mendiola, M. S., Ochoa‐Hein, E., Vázquez-Rivera, M., Gutiérrez‐Cirlos, C., Naveja, J., & Martínez-González, A. (2022) · Figshare · doi:10.6084/m9.figshare.20070906
Li, M., Zhang, D., Yang, Q., Zhao, Z., Zhang, C., Zhou, Y., Bai, Y., Chen, L., Tang, X., Liu, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26737632
Luo, W., Lin, Y., Li, Z., Wang, W., & Shi, Y. (2020) · Figshare · doi:10.6084/m9.figshare.12368018
Li, M., Zhang, D., Yang, Q., Zhao, Z., Zhang, C., Zhou, Y., Bai, Y., Chen, L., Tang, X., Liu, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26082614
Li, M., Zhang, D., Yang, Q., Zhao, Z., Zhang, C., Zhou, Y., Bai, Y., Chen, L., Tang, X., Liu, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26737629
Li, M., Zhang, D., Yang, Q., Zhao, Z., Zhang, C., Zhou, Y., Bai, Y., Chen, L., Tang, X., Liu, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26082722
Ong, H. T., Leong, R. W. L., & Gan, J. Y. (2025) · Cureus · doi:10.7759/cureus.100362
“Evaluation of suspected laryngeal TB should include adjunct investigations such as AFB smears and cultures, bacterial cultures, and TB PCR analysis of tissue or fluid samples [15].”
Fan, Q., Chen, J., Wang, Y., Liao, R. J., Gong, S., Guo, J., Rao, Y., Fang, T., Hu, S., Chen, L., et al. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108429 · Cited by 1
Tao, Y., Liu, X., Liu, Y., Ma, Y., Liu, Y., & Ding, M. (2026) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2025.100578
“However, it should be noted that in countries with a high tuberculosis burden, the clinical value of T-SPOT in distinguishing active tuberculosis from latent infection is inherently limited [23].”
Kanokogi, T., Urabe, N., Tokita, N., Murakami, H., Sasaki, M., Sakamoto, S., & Kishi, K. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.02442-25
“Accordingly, to maximize the diagnostic sensitivity of conventional microscopy and culture, the 2017 American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention guidelines recommend the collection of three sputum specimens (3).”
Yamamoto, K., Imabayashi, T., Tanaka, T. T., Jinno, K., Tanaka, S., Uda, S., Yuba, T., & Takumi, C. (2026) · Respiratory Investigation · doi:10.1016/j.resinv.2026.101379
Kim, K. E. S., Lee, Y. J., Park, J. S., Kwak, N., Kim, S.-Y., Jhun, B. W., Yim, J., & Shin, S. J. (2026) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2026.103162
Ganicho, J., Dinis, D. V. D. S., Gião, N., Carlos, M., Cruz, C., Santos, M. L., Garrote, A. R., Maltêz, F., & Manata, M. J. (2026) · Revista Portuguesa de Doenças Infecciosas (RPDI) · doi:10.65332/rpdi.v20.125
Lan, N., Tang, L., Liu, J., Xu, X., Liu, C., & Zhang, G. (2026) · Research Square · doi:10.21203/rs.3.rs-8567341/v1
Sabella-Jiménez, V. L., Sabella‐Jiménez, V., Estupiñán-Bohorquez, A. F., & Acosta-Reyes, J. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-105136
Prodanuk, M., King, J. W., Cunningham, J., Kitai, I., Piché‐Renaud, P., Ratnayake, M., Morris, S. K., & Richard‐Greenblatt, M. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.02.025 · Cited by 1
Lower Respiratory Tract Infections
Thivierge-Southidara, M., & Lawandi, A. (2026) · Critical Care Clinics · doi:10.1016/j.ccc.2025.12.009
An Atypical Presentation of Tuberculosis With the Involvement of the Thoracic Aorta
Namazi, S., & Hou, C. M. (2026) · Cureus · doi:10.7759/cureus.106797
“In one series, TB was identified in aortic tissue in only three of 11 patients with suspected TA, reflecting the broader challenge of diagnosing extrapulmonary TB, where mycobacterial culture sensitivity is more limited [5,13].”
Diagnostic determinants of acid-fast bacilli culture positivity in miliary TB
Yang, J., Choi, M., Yi, K. S., Lee, Y. J., Kim, E. C., Min, G., Kim, M., Park, E., Cho, J. Y., Shin, Y. M., et al. (2026) · IJTLD OPEN · doi:10.5588/ijtldopen.25.0579
QuantiFERON-TB gold test: a valuable diagnostic tool for tubercular uveitis in non-endemic regions
Albus, S., Koch, A., Pleyer, U., Rübsam, A., Sander, L. E., Witzenrath, M., Menner, N., Bonsen, L. Z., & Pohlmann, D. (2026) · Infection · doi:10.1007/s15010-026-02789-9
“While pulmonary TB is the best known presentation, extrapulmonary TB is common and causes significant morbidity and mortality [2–5].”
Chaitra, C. S., Nevil, S., & Charles, S. A. (2026) · The Indian Journal of Medical Research · doi:10.25259/ijmr_283_2026
NARRA, T. (2026) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2026.102427
Gutiérrez, C. H., Moreno, J. S., Queirolo, B. L., & Mena, M. N. (2026) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2026.04.011
Mena, M. N., Garcia, G. M., Moro, A. L., & Moreno, J. S. (2026) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2026.04.010
Protocolo diagnóstico y terapéutico de la infección tuberculosa latente
Cifuentes, R. P., Moreno, J. S., García, D. C., & Garcia, G. M. (2026) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2026.04.017
Hariri, B. A., Sharif, M., Illahi, M. N., Eltigani, A. M. A., Anbagi, U. S. M. A., & Ahmad, M. K. K. (2026) · Clinical Case Reports · doi:10.1002/ccr3.72230
Preventing the Spread of Tuberculosis in Healthcare Settings
Grijalva, M. I., & Zuckerman, J. M. (2026) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2026.03.001
Analytical Review of Diagnostic Methods of Female Genital and Peritoneal Tuberculosis
Соцкий, П. О., Sotskaya, O. L., & Safarian, M. D. (2026) · Tuberculosis and lung diseases · doi:10.58838/2075-1230-2026-104-2-110-120
Tesfay, F., Dawit, H., Mehari, H., Ghebregziabiher, M., & Mussie, L. (2026) · Journal of Medical Case Reports · doi:10.1186/s13256-026-06111-x
Infection in Solid Organ Transplant: Prevention, Risk, and Treatment Strategies
Kopf, S., Banbury, J., & Kopf, R. S. (2026) · AACN Advanced Critical Care · doi:10.4037/aacnacc2026271
Atypical Cerebral Tuberculosis: Contending With the Diagnostic Challenge
Ashwinee, A., Mejia, S. H., Cho, A., Kurtca, M., & Arulthasan, M. (2026) · Cureus · doi:10.7759/cureus.110080
Figueroa-Ortiz, C. J., Schoninger, S., Chan, J. L., Bermudez, T. A., Li, Y., Cander, S., McGonagle, B., Bacon, C. W., Kalchiem‐Dekel, O., Chawla, M. K., et al. (2026) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2026.06.007
Zhang, J., 沈兴华, Liu, J., Xu, J., Huang, L., Ni, H., Tang, P., Feng, Y., Wu, M., & Shi, C. (2026) · Infection and Drug Resistance · doi:10.2147/idr.s598998
“4,36 In addition to this structural vulnerability, concurrent diabetes mellitus and malnutrition may further compromise host immune defenses.”
Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds
Alabed, S. T., & Finkel, D. (2026) · International Ophthalmology · doi:10.1007/s10792-026-04134-3
“When the ocular phenotype is highly compatible, disease is vision-threatening, and alternatives have been carefully excluded, treatment may still be justified after multidisciplinary discussion, even without IGRA/TST positivity [19, 30, 34].”
Tian, R., Cui, X., Wang, L., Yan, L., & Wang, P. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13834-1
Usman, M., Murtaza, L., Paramasivam, K., LATCHMAN, K., & Dhaliwal, K. (2026) · Cureus · doi:10.7759/cureus.111589
Keeratichananont, W., Keeratichananont, S., Ubonsutvanich, N., & Chaisurote, J. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00581-26
Alahmari, H., Hanson, L., Kelley, P., Spong, J., Milazzo, A., & Mnatzaganian, G. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108949
Hong, M., Ji, L., Gao, J., Zhang, H., Ge, S., & Yuan, C. (2026) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2026.152684 · Cited by 1
Ter-Ovanesyan, I., Pedreira, C., Memari, K., Sizova, A., Ramirez-Matos, C., Williams, S., Cohen, P., & Lazo, L. P. (2026) · Cureus · doi:10.7759/cureus.112415
“Therefore, a negative result should not override a high pretest probability based on symptoms, epidemiologic risk, and imaging [6].”
InfluentialMehta, S., Prabhu, M. M., Vivek Nayak, M., & Lakshmi, S. (2026) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2026.2694292
Bronchiectasis and Mycobacterial Infections in Older Adults
Peterson, J., Jones, M., & Losier, A. (2026) · Respiratory medicine · doi:10.1007/978-3-032-29861-4_14
Durairaj, E., Rajbongshi, J., & Vincent, M. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016368
DECIDE-Lab: A Value-of-Information and POMDP Framework for Diagnostic Laboratory Test Selection
Allenbrand, C. (2026) · Diagnostics · doi:10.3390/diagnostics16152356
“The belief state includes symptoms, exposure risk, country of origin, immune suppression, radiographic findings, and local prevalence [36,37].”
Hotaman, B., & Cağdaş, D. N. (2026) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000005354
Real and Perceived Risks from Live Viral Vaccines
Giuliani, A. A. M., & Pannaraj, P. S. (2026) · Springer eBooks · doi:10.1007/978-1-0716-5464-4_21
Ekeng, B. E., Egbara, W. O., Adereti, O. C., Bassey, T. E., Agwu, I. F., Araga, A. N., Onukak, A. E., Odo, H., James, A., Ukpeh, I. E., et al. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02660-w
Gharsalli, H., Mohammed, S. A., ALAsiri, A. M., Jali, M. A., Alwadai, N. M. F., Boussafsaf, A., Basheer, N. A., AlDossari, M. S., Khedrah, A. M., Alshahrani, M., et al. (2026) · Journal of Fungi · doi:10.3390/jof12090671
“…tissue and the surgical mediastinal lymph-node tissue, and cultures were incubated for 6 weeks in liquid (MGIT) medium and 8 weeks on Löwenstein– Jensen solid medium in accordance with standard recommendations for mycobacterial culture [7]; all remained negative at the end of incubation.”
Classification of Lung Diseases from CXR Images Using Transfer Learning with Hyperparameter Tuning
Wajgi, R. D., Wanjari, B., Verma, S., Wajgi, D., Deshmukh, A., Mallewar, S., & Gode, S. (2026) · Lecture notes in networks and systems · doi:10.1007/978-3-032-27845-6_12
MDT-guided language-model reasoning for spinal infection diagnosisPreprint
Chen, J., Zhang, R., Xu, C., Li, H., 胡维维, Cai, L., Ma, S., Meng, Y., Li, X., Chen, Y., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10692703/v1
Giangregorio, F., Civaschi, E., Mazzocchi, S., ROMANO, D., Clini, P. V., Centenara, E., Casale, U., Catucci, D., & Imberti, D. (2026) · Livers · doi:10.3390/livers6050096
Prieto-García, R., Millet, J.-P., Masferrer, M. B., Ospina, J. E., Parrón, I., Orcau, À., Clotet, L., Despuig, A., García‐Basteiro, A. L., Rius, C., et al. (2026) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2026.07.006
Kim, H., Park, J. E., Kim, S., Lee, J. H., Shin, D. W., Lee, K., Hong, Y. J., & Park, K. U. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.02159-26
Sathyanarayana, P. K. K., Mathew, K., Murtaza, G., Pierre-Robson, K. S., & Gonzalez, M. V. (2026) · BMJ Case Reports · doi:10.1136/bcr-2026-275619
Horne, D. J. D. L., Zifodya, J. S., Ejara, E. D., Coston, T. D., Shapiro, A. E., Kohli, M., Schumacher, S. G., Hall, P., Korobitsyn, A., & Takwoingi, Y. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016396
The Effect of Air Pollutants on Exacerbation of Pulmonary Tuberculosis: A Review
Saleem, H. M., Abdulazez, A. A., Alshkarchy, S. S., Kadhum, W. R., Rudiansyah, M., & Mohammadi, M. J. (2026) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid-167376
Sherman-Daniels, E., Salwa Raheel, B. S., Basso, V., Kowalski, K., Moronta, C., Vaze, B. P., Schluger, N. W., & Montecalvo, M. A. (2026) · Research Square · doi:10.21203/rs.3.rs-11107129/v1
Kim, K. Y., Kim, H.-B., & Lee, Y. K. (2026) · Microorganisms · doi:10.3390/microorganisms14112471
Metadata
- Authors
- Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., Keane, J., Lewinsohn, D. A., Loeffler, A. M., Mazurek, G. H., O’Brien, R. J., Pai, M., Richeldi, L., Salfinger, M., Shinnick, T. M., Sterling, T. R., Warshauer, D. M., & Woods, G. L.
- Affiliations
- Oregon Health & Science University (US)
- Emory University School of Medicine and
- Centers for Disease Control and Prevention (US)
- Denver Public Health (US)
- National Jewish Health (US)
- California Department of Public Health (US)
- St. James's Hospital (IE)
- Francis J. Curry International TB Center, San Francisco, California;
- FIND (CH)
- McGill University (CA)
- University of Southampton (GB)
- Vanderbilt University (US)
- Wisconsin State Laboratory of Hygiene, Madison, and
- University of Arkansas for Medical Sciences (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-08
- Volume
- 64
- Issue
- 2
- Pages
- e1-e33
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5504475
- OpenAlex
- W2559832962
- Cited by
- 992
- References
- 246
- Citations by year
- 2026: 65 · 2025: 81 · 2024: 91 · 2023: 101 · 2022: 115 · 2021: 142 · 2020: 133 · 2019: 110 · 2018: 96 · 2017: 55 · 2016: 1
- FWCI
- 80.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis diagnosis, latent tuberculosis infection, pulmonary tuberculosis, extrapulmonary tuberculosis, Mycobacterium tuberculosis, diagnostic testing, children, adults
- MeSH terms
- Adult, Age Factors, Child, Humans, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Pulmonary, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.